AMPS and the art of questioning a medical bill

A hospital bill has a peculiar social advantage: it arrives dressed as a fact. Codes, dates, quantities, a total. Everything looks settled. The arithmetic may be impeccable while the price deserves an argument. AMPS has built a business in that uncomfortable space between receiving a claim and deciding what ought to be paid.

Consider Sunwest Bank. In AMPS’s account, the bank was already using reference-based pricing, an approach that calculates reimbursement against a benchmark such as Medicare rather than simply accepting a network discount. But its experience depended heavily on its third-party administrator. When the bank sought a new administrator, it also went looking for a more transparent pricing partner. The trouble was in the arrangement around the calculation.

A bank discovers that simplicity has a supply chain

Sunwest chose AMPS for transparency, reporting, and cooperation with its administrator, according to the company’s case study. AMPS says it corrected billing errors and repriced claims at a percentage of Medicare rates. The reported outcome was $1.2 million in savings over two years, with low balance bill activity.

That example is interesting because the bank’s search began with a change of partner. Software does not exist in splendid isolation. It depends on claims arriving, reports making sense, and the administrator and pricing vendor agreeing on who does what. A benefits manager may understand the formula perfectly and still spend the afternoon untangling the workflow.

The customer quotation AMPS publishes is wonderfully modest: “AMPS has made RBP simple.” Simplicity is a substantial product when the alternative requires employees to become amateur billing specialists.

Three questions hidden inside one expense

Advanced Medical Pricing Solutions sells software and services to self-funded employers, health plans, administrators, brokers, and related organizations. An employer paying its own medical claims has a direct interest in whether each payment is accurate. A TPA processes those benefits. A broker helps assemble the arrangement. AMPS works within that machinery.

Its three main businesses separate questions that a total expenditure can obscure. ClaimInsight asks whether the claim is correct. PriceDynamix asks how the medical service should be priced and how that payment will be supported. Drexi addresses prescription benefits. Buyers can use the businesses independently or together.

The distinction matters. Correcting an inappropriate charge and negotiating reimbursement are different jobs. A pharmacy contract introduces another set of incentives. Trying to solve all three by admiring a single discount percentage is rather like judging a restaurant by the size of the crossed-out price on its menu.

The physician’s second examination

ClaimInsight’s High-Dollar Review puts practicing, licensed physicians to work on itemized inpatient bills. The service examines charges line by line, looking for issues such as excessive charges and level-of-service overbilling. Its advertised review thresholds can begin at $25,000. AMPS says customers can submit the claim and itemized bill without undertaking a full IT integration.

This is expertise applied to a different object. A clinician understands the relationship between what happened during care and what appears on the invoice. The value of that judgment is in explaining a finding persuasively enough to survive a challenge.

Alongside that review, Intelligent Policy Update supplies automated prepayment editing. ClaimInsight describes a rules engine informed by coding and payment policies, with visibility into why an edit was applied. The wider suite also includes Clarity Medical Bill Review and retrospective review and recovery. Prevention and recovery occupy different moments in the payment process; the buyer needs to know which moment a proposed service actually addresses.

The price must survive the envelope

PriceDynamix combines repricing with direct facility contracts, legal and negotiation teams, care navigation, and member advocacy. Care navigation helps members locate providers and arrange high-cost elective procedures. Advocacy supports them through balance billing issues. AMPS Connect provides provider-search and billing tools.

These are operational answers to an obvious difficulty: a reimbursement calculation does not, by itself, persuade a provider to accept the payment. The patient can become the unwilling courier between two organizations disagreeing about money. A pricing service therefore needs an account of what happens after the number leaves the screen.

“The real disconnect with traditional RBP has always been how members are treated through the process.”Michael Condon, AMPS · April 2025

That admission gives AMPS’s positioning some substance. Its pitch bundles the calculation with people responsible for the consequences. The product page reports more than 1,700 PriceDynamix clients and $2.25 billion in savings. Those are AMPS’s figures; the page does not define the measurement period or provide enough detail to reproduce the aggregate.

Nor does AMPS have the territory to itself. 6 Degrees Health offers reference-based pricing with member support, contracting, and legal assistance. The Phia Group combines pricing support with legal and plan services. Cotiviti sells payment integrity technology. The competitive question is how the particular combination fits a buyer’s claims, providers, staff, and existing systems.

A pharmacy result with a small but important footnote

Drexi advertises pass-through prescription pricing through more than 65,000 pharmacies and a fixed fee per employee. Its employer platform provides claims visibility and reporting; its member tools show local prescription prices and track medication history. The model gives procurement teams something concrete to examine: administration charges alongside the cost of the drugs.

In a case study of an unnamed nationwide physician practice, AMPS reports $612,000 in savings during the first seven months of 2025. The program combined international sourcing, manufacturer and patient assistance, and personalized advocacy. The reported 44% reduction concerned targeted medications. It was not presented as a 44% reduction in every dollar of the employer’s pharmacy spending.

The distinction is the story. Expensive medications can deserve focused interventions, and the work can require individual assistance rather than a new price list alone. For this case, AMPS says 195 members received international-program advocacy support. Eligibility, medication mix, and the suitability of each program will shape what another employer can achieve. A published example provides a question to investigate, not a budget to copy.

Capital follows the expanding brief

Current company materials date AMPS to 2005. Founder Mike Dendy came from the benefits administration world; a Marpai regulatory filing describes his earlier sale of HPS Paradigm Administrators in 2004. His subsequent AMPS business focused on medical bill review and reference-based reimbursement.

The company’s later milestones show a widening assignment. Cimarron Healthcare Capital led a recapitalization in 2017 with RAF Industries, Leavitt Equity Partners, and management. AMPS announced the acquisition of Drexi in January 2021, extending its cost management suite into prescriptions. Matt Brow became CEO in 2023. Cimarron’s news archive records the ClaimInsight automated-review business line in March 2024, before AMPS promoted a broader suite in 2025.

In April 2025, Crestline announced a senior secured loan to support growth and new offerings. June brought TruPrice, software for contract and out-of-network repricing. The important detail is contract compatibility: AMPS describes support for network, professional, ambulatory surgery center, health system, and direct-to-employer agreements. Translating an agreement into the correct payment is a product in its own right.

In December 2025, AMPS announced HITRUST e1 certification for its enterprise systems, covering foundational cybersecurity controls. For a business handling sensitive claims information, security assurance belongs in the buying decision alongside savings and speed.

The work a buyer can borrow

AMPS’s business model combines proprietary SaaS with services. Drexi describes its fee structure, while the other offerings require a tailored commercial conversation. PriceDynamix also advertises a performance guarantee customized to the plan. A buyer should translate that promise into written terms: covered claims, measurement baseline, fees, exclusions, and responsibility for disputes.

The practical lesson travels beyond AMPS. Separate billing accuracy from pricing. Test how the vendor and administrator exchange information. Ask what members do when a provider challenges payment. Compare realized savings after fees with the starting baseline. A plan with little exposure to the claims being targeted, unsuitable pharmacy-program participants, or limited access to necessary billing detail may see a very different result.

The company’s published culture emphasizes accountability and collaboration. Its Atlanta volunteer visit supplies a tangible glimpse of employees working together, though a photograph cannot audit a workplace. The more consequential test of those values is in the everyday handoff: a flagged charge, an explained decision, a member who knows whom to call.

AMPS is selling the capacity to question a bill and then do the less glamorous work that follows. The number matters. So does whether the employer, administrator, provider, and patient can live with it after the spreadsheet closes.